Error message

The page you requested does not exist. For your convenience, a search was performed using the query cbssm med umich edu people christian vercler md ma.

Page not found

You are here

People

Our People

CBSSM is an interdisciplinary group committed to improving individual and societal health through research, education, and public outreach. Our unit attracts scholars from across departmental and disciplinary boundaries and in so doing, provides fertile ground for new synergies. CBSSM affiliates with scholars from across the University of Michigan and the Ann Arbor VA Health System to collaborate on research projects.

Our team includes:

  • Social and cognitive psychologists
  • Bioethicists
  • Clinicians from many medical specialty areas
  • Public health researchers
  • Decision scientists
  • Behavioral economists
  • Survey methodologists
Mon, April 17, 2017

Brian Zikmund-Fisher is quoted in a recent MarketWatch article, "How doctors are getting patients more involved in their own care." Dr. Zikmund-Fisher points out, "Patients are often overwhelmed by massive amounts of data they now have access to. The easier we make it for them to understand, the more likely it is they will use it and the less time the doctor has to spend explaining it.” The article goes on to cite a web-based application developed by Dr. Zikmund-Fisher and colleagues that allows health-care providers and researchers to create graphics that use icons in arrays that show risk information in ways that make it easier for people to grasp information.

A study by former CBSSM Co-Director, Angela Fagerlin, is also cited in the article.

Funded by the Alzheimer's Association

Active Year(s): 2008-2011

The goal of the MCI Risk Communication Study is to develop and evaluate a risk communication protocol to convey diagnostic and risk information to MCI patients and family members. A multi-step protocol will be created, taking into account principles of health risk communication, patient and provider preferences, and ethical issues involved in working with cognitively impaired populations. The protocol will be delivered by health care professionals with risk communication experience and tested on 10 patient/care-partner dyads recruited from Alzheimer’s Disease Centers at the University of Michigan and Boston University. The results of this pilot study will help inform the fourth trial of REVEAL.

PI: J. Scott Roberts, PhD

Tue, January 10, 2017

Jeffrey Kullgren was recently featured in the Michigan Medicine article, "What do health plan deductibles really mean for people with chronic illness? New study takes a look." Dr. Kullgren co-authored a JAMA Internal Medicine Research Letter, which reports that even “low” deductible plans can mean high out-of-pocket costs for many Americans.

Funded by the National Institutes of Health/Brigham and Women's Hospital/Boston University

Funding years: 2010-2013

The rapid identifcation of genetic risk factors for common, complex diseases poses great opportunities and challenges for public health. Genetic information is increasingly being utilized as part of commercial effors, including direct-to-consumer (DTC) genetic testing to provide risk information on common diseases to consumers. Very few empirical data have been gathered to understand the characteristics of DTC test consumers, the psychological, behavioral and health impact (clinical utility), and the ethical, legal and social issues associated with DTC services.

In the proposed research, we will survey users of the two leading US companies providing DTC genetic testing (23andMe and Navigenics) regarding their response to genetic test s for common diseases of interest, including heart disease, diabetes, Alzheimer's disease (AD), arthritis, and breast, colon, lung and prostate cancers. Each company now has thousands of customers and each anticipates extensive sales in coming years. Each has agreed to allow our group to survey consumers using third-party data collection and analysis procedures that will enable an independent consideration of the benefits and risks of DTC testing in this format. The companies have also agreed to provide genetic test information (with respondents' permission) for analyses. A total of 1000 consumers (500 from each company) website will be surveyed via the Internet at three time points: 1) before receipt of genetic test results; 2) approximately two weeks following receipt of test results; and 3) six months following receipt of results.

More information: http://www.psc.isr.umich.edu/research/project-detail/35031

PI: Scott Roberts

Co-I: Mick Couper

The University of Michigan is seeking a nominee to the national competition for the Greenwall Foundation Faculty Scholars Program in Bioethics. The October 1st internal deadline has been extended. Details can be found at: http://orsp.umich.edu/funding/limited_submissions/greenwall.html.

CBSSM Seminar: Peter A Ubel, MD

Tue, April 10, 2018, 3:00pm
Location: 
NCRC, Building 16, Room 266C

Peter A Ubel, MD

Professor of Business Administration
Madge and Dennis T. McLawhorn University Professor
Professor in the Sanford School of Public Policy
Professor of Medicine
Affiliate of the Duke Initiative for Science & Society
Member of the Duke Cancer Institute

“The Ethics of Nudges: An Informal Discussion”

This will be an informal discussion with Dr. Ubel, CBSSM faculty, and others to discuss their research around the ethics of nudges.

 

CBSSM Seminar: Darin Zahuranec, MD

Wed, January 20, 2016, 3:00pm to 4:00pm
Location: 
NCRC, Building 16, Room 266C

Darin Zahuranec, MD


Assistant Professor, Neurology

Title:  Improving decisions on life-sustaining treatments after stroke

Abstract:  Individuals with acute stroke face the sudden onset of new deficits, along with a need to make many decisions about medical treatments with impact on the potential for survival and long-term disability. This talk will review the challenges in decision-making after acute stroke and discuss possible solutions for the future.

 

CBSSM Seminar: Geoffrey Barnes, MD

Tue, October 30, 2018, 3:00pm
Location: 
NCRC, Building 16, 266C

Geoffrey Barnes, MD
Assistant Professor, Internal Medicine

Title: Peri-endoscopy Antithrombotic Management: Using Systems Engineering to Improve Clinical Decision-Making

Abstract: Surgical procedures, such as gastrointestinal endoscopy, present management challenges for patients taking chronic antithrombic medications. Following an in depth analysis of current practices, we re-organized care delivery to standardize clinical decision making for these patients using health systems engineering and implementation science methods.

CBSSM Working Group Meeting-Chithra Perumalswami, MD

Tue, January 22, 2019, 4:00pm
Add to Calendar
Location: 
NCRC B016-266C

Chithra Perumalswami, MD, MSc, will be seeking feedback on a mail survey of oncologists to understand chemotherapy use in patients with advanced cancer near the end of life. This survey represents the quantitative portion of the convergent parallel mixed methods design and complements the qualitative portion presented at the working group in November.

Pages